Skip to main content
. 2020 Feb 21;25:7. doi: 10.1186/s12199-020-00844-x

Table 1.

Characteristics of the study population

Total Men Women
No. of participants 1432 532 900
No. of case (%) 469 (32.8) 146 (27.4) 323 (35.9)
TPO-Ab, (< 16) IU/mL 9 [7, 13]*1 9 [7, 12]*1 9 [7, 13]*1
Age, year 60.9 ± 9.0 62.4 ± 8.7 59.9 ± 9.1
TSH, (0.39–4.01) μIU/mL 1.59 [1.11, 2.28]*1 1.53 [1.07, 2.16]*1 1.61 [1.13, 2.33]*1
Free T3, (2.1–4.1) pg/mL 3.2 ± 0.3 3.3 ± 0.3 3.1 ± 0.3
Free T4, (1.0–1.7) ng/dL 1.2 ± 0.2 1.3 ± 0.2 1.2 ± 0.1
BMI, kg/m2 22.8 ± 3.4 23.6 ± 3.1 22.4 ± 3.5
SBP, mmHg 125 ± 17 129 ± 14 123 ± 18
Anti-hypertensive medication, % 30.9 38.7 26.3
HbA1c, % 5.6 ± 0.6 5.7 ± 0.7 5.6 ± 0.6
TG, mg/dL 105 ± 73 123 ± 91 95 ± 56
HDLc, mg/dL 61 ± 15 54 ± 14 64 ± 14
Menopause, % 50.3 80.0

TPO-Ab anti-thyroid peroxidase antibody, TSH thyroid-stimulating hormone, free T3 free triiodothyronine, free T4 free thyroxine, BMI body mass index, SBP systolic blood pressure, TG triglycerides, HDLc high-density lipoprotein cholesterol

No. of case is the number of participants with thyroid cyst. Values are mean ± standard deviation

*1Values are median [the first quartile, third quartile]. Normal range of measurements are ( )